Medical studies and clinical trials have shown that patients taking diabetes medications such as Invokana (canagliflozin), Invokamet (canagliflozin and metformin), Farxiga, Jardiance and other SGLT2 inhibitors may face an increased risk of serious and potentially life-threatening side effects, including diabetic ketoacidosis, amputation of limbs and toes, kidney failure, chronic kidney disease, heart attack, stroke, bone density loss and severe blood infections. If you took Invokana or another SGLT2 drug to treat diabetes, and you have since been diagnosed with a serious medical complication, you may be entitled to financial compensation for your losses. Qualify today to file a claim for compensation from Johnson & Johnson and its Janssen Pharmaceuticals unit and the other manufacturers of these dangerous drugs.